Cleaved protein S (PS), total PS, free PS, and activated protein C cofactor activity as risk factors for venous thromboembolism

Clinical Chemistry

Volumn 49, Issue 4, 2003, Pages 575-580

  Borgel, Delphine ^a   Reny, Jean Luc ^b,c   Fischelis, David ^a   Gandrille, Sophie ^a   Emmerich, Joseph ^b,c   Fiessinger, Jean Noël ^b,c   Aiach, Martine ^a  

^a AP HP   (France)

^b Service des Maladies Vasculaires   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ACTIVATED PROTEIN C COFACTOR; CLEAVED PROTEIN S; PROTEIN S; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; GENDER; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN S DEFICIENCY; QUANTITATIVE DIAGNOSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTIBODIES, MONOCLONAL; CASE-CONTROL STUDIES; COMPLEMENT C4B; COMPLEMENT INACTIVATOR PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; MALE; PROTEIN C; PROTEIN S; PROTEIN S DEFICIENCY; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0037381034     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.4.575     Document Type: Article

References (35)

1. Mahasandana C, Suvatte v, Chuansumrit A, Marlar RA, Manco-Johnson MJ, Jacobson LJ, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990;117:750-3.
2. Pegelow CH, Ledford M, Young JN, Zilleruelo G. Severe protein S deficiency in a newborn. Pediatrics 1992;89:674-6.
3. Millar DS, Allgrove J, Rodeck C, Kakkar V, Cooper DN. A homozygous deletion/insertion mutation in the protein C (PROC) gene causing neonatal purpura fulminans: prenatal diagnosis in an at-risk pregnancy. Blood Coagul Fibrinolysis 1994;5:647-9.
4. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 1994;71:441-5.
5. Engesser L, Broekmans AW, Briet E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987;106:677-82.
6. Walker FJ, Chavin SI, Fay PJ. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys 1987;252:322-8.
7. Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979;571:333-42.
8. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A 1994;91:2728-32.
9. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993;268:2872-7.
10. Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII. Blood 1995;86:1062-71.
11. Morboeuf O, Borgel D, Gaussem P, Vincenot A, Pittet JL, Aiach M, et al. Characterization of cleaved plasma protein S with a monoclonal antibody-based assay. Thromb Haemost 2000;84:604-10.
12. Long GL, Lu D, Xie RL, Kalafatis M. Human protein S cleavage and inactivation by coagulation factor Xa. J Biol Chem 1998;273:11521-6.
13. Borgel D, Gaussem P, Garbay C, Bachelot-Loza C, Kaabache T, Liu WQ, et al. Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the γ-carboxy-glutamic acid-rich domain. Biochem J 2001;360:499-506.
14. Dahlback B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci U S A 1981;78:2512-6.
15. Zoller B, Garcia de Frutos P, Dahlback B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995;85:3524-31.
16. Koster T, Rosendaal FR, Briet E, van der Meer FJ, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995;85:2756-61.
17. Faioni EM, Valsecchi C, Palla A, Taioli E, Razzari C, Mannucci PM. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost 1997;78:1343-6.
18. Liberti G, Bertina RM, Rosendaal FR. Hormonal state rather than age influences cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency. Thromb Haemost 1999;82:1093-6.
19. Persson K, Hillarp A, Dahlback B. Analytical considerations for free protein S assays in protein S deficiency. Thromb Haemost 2001;86:1144-7.
20. Meyer G, Emmerich J, Helley D, Arnaud E, Nicaud V, Alhenc-Gelas M, et al. Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med 2001;110:12-5.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
22. Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost 1999;81:506-10.
23. Giri TK, Hillarp A, Hardig Y, Zoller B, Dahlback B. A new direct, fast and quantitative enzyme-linked ligand sorbent assay for measurement of free protein S antigen. Thromb Haemost 1998;79:767-72.
24. Makris M, Leach M, Beauchamp NJ, Daly ME, Cooper PC, Hampton KK, et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 2000;95:1935-41.
25. Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998;92:2353-8.
26. Simmonds RE, Zoller B, Ireland H, Thompson E, de Frutos PG, Dahlback B, et al. Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes. Blood 1997;89:4364-70.
27. Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987;69:692-4.
28. Wolf M, Boyer-Neumann C, Leroy-Matheron C, Martinoli JL, Contant G, Amiral J, et al. Functional assay of protein S in 70 patients with congenital and acquired disorders. Blood Coagul Fibrinolysis 1991;2:705-12.
29. Griffin JH, Gruber A, Fernandez JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood 1992;79:3203-11.
30. Mustafa S, Mannhalter C, Rintelen C, Kyrle PA, Knobl P, Lechner K, et al. Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden. Blood Coagul Fibrinolysis 1998;9:85-9.
31. Koeleman BP, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 1995;74:580-3.
32. Zoller B, Berntsdotter A, Garcia de Frutos P, Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995;85:3518-23.
33. Castaman G, Tosetto A, Cappellari A, Ruggeri M, Rodeghiero F. The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency. Blood Coagul Fibrinolysis 2000;11:321-6.
34. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000;101:1546-51.
35. Espinosa-Parrilla Y, Yamazaki T, Sala N, Dahlback B, de Frutos PG. Protein S Secretion differences of missense mutants account for phenotypic heterogeneity. Blood 2000;95:173-9.